Healthcare >> CEO Interviews >> May 29, 2000

Harvey Berger – Ariad Pharmaceuticals Inc (aria)

HARVEY J. BERGER, MD, is ARIAD's principal Founder and has served as its Chairman of the Board, President and Chief Executive Officer since April 1991. From 1986 to 1991, Dr. Berger held a series of senior management positions at Centocor, Inc., a biotechnology company, most recently as Executive Vice President and President of the Research and Development Division. He also has held senior academic and administrative appointments at Emory University, Yale University and the University of Pennsylvania and was an Established Investigator of the American Heart Association. Dr. Berger received his BA degree in Biology from Colgate University, his MD degree from Yale University School of Medicine and did further medical and research training at the Massachusetts General Hospital and Yale-New Haven Hospital. Profile
TWST: Could you begin by giving us an overview of ARIAD Pharmaceuticals,

Inc.? Then describe how you see the business today.

Dr. Berger: ARIAD is focused on the discovery, development